Qiagen NV (QGEN) PT Raised to $52 at TD Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts QGEN Hot Sheet
Price: $45.09 -0.64%
Rating Summary:
15 Buy, 16 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Rating Summary:
15 Buy, 16 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Join SI Premium – FREE
TD Cowen analyst Dan Brennan raised the price target on Qiagen NV (NYSE: QGEN) to $52.00 (from $49.00) while maintaining a Hold rating.
You May Also Be Interested In
- Biogen (BIIB) PT Raised to $220 at BMO Capital
- Alignment Healthcare Inc (ALHC) PT Lowered to $12 at TD Cowen
- Alibaba (9988:HK) (BABA) PT Raised to HK$195.70 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
